Contribute Try STAT+ Today

In an unusual move, a coalition of cystic fibrosis patients and their families have filed a complaint with the United Nations, arguing that Vertex Pharmaceuticals (VRTX) is harming patient rights through prohibitive pricing and distribution policies for its life-saving medicines.

Specifically, the group maintained that Vertex is violating UN policies on attaining standards for public health, which were issued in 2000 and maintain that health is a “fundamental human right.” Their hope is that the UN Human Rights High Commission will investigate Vertex business practices and release findings that could be used by patients to pressure their countries to press for greater affordability.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.